ALS drug Relyvrio withdrawn from market after failed clinical trial

Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial.…
Read More